However, since our genetic analyses in C. elegans indicated that negative regulation of RAS-MAPK signaling by LRIG/SMA-10 required the presence of EGFR/LET-23, we hypothesized that a tumor-suppressive function of LRIG1 may be exerted at the EGFR level. The gene discussed is EGFR; the disease is neoplasm.